HOME > Nyheter & Pressmeddelanden > Nyheter & pressreleaser

Tillåter behandling av personuppgifter
Ange e-postadress
Invalid email
Email Sent
Tillåter behandling av personuppgifter
Juny 2020
08 June
Chiesi Nordics supports employees, patients and caregivers during the Covid-19 pandemic
April 2020
28 April
Rengöring av AeroChamber Flow-Vu
March 2020
30 March
Chiesi Group increases support measures and announces new funds for employees, patients and...
Febrary 2020
06 February
Chiesi Group Announces Establishment of New Global Rare Diseases Division
Dicember 2019
04 December
Chiesi investerar 350 miljoner EURO i den första koldioxidsnåla sprayinhalatorn för astma och KOL
May 2019
10 May
Paolo Chiesi blir hedersdoktor vid Karolinska Institutet
Febrary 2019
15 February
Chiesi Group receives the EURORDIS Black Pearl award for innovation in the field of Rare Disease.
November 2018
21 November
World COPD Day - COPD, a disease still underestimated by Europeans: absence of perceived risk,...
Juny 2018
01 June
Chiesi Group stärker Chiesi Pharma AB i Norden genom integrering av Zymenex
October 2017
04 October
TLV-subvention för Chiesis nya trippelkombination vid KOL
September 2016
02 September
The Lancet publishes the results of Chiesi Farmaceutici TRILOGY study
Febrary 2016
15 February
Chiesi is Top Employers again!
November 2015
30 November
Alberto, Paolo and Andrea Chiesi winners of the “Entrepreneur of the year 2015” Award
26 November
Special Mention to Holoclar at the Italian Galeno Award
September 2015
24 September
Läkemedlet Envarsus har fått subvention av TLV
April 2015
02 April
Chiesi tra le prime 10 aziende più ambite dai lavoratori
March 2014
21 March
COPD indication for Foster pMDI
14 March
Double-digit growth and internal expansion for the Chiesi Group